By Colin Kellaher Bristol Myers Squibb on Monday said data from a Phase 2 study of BMS-986278 in idiopathic pulmonary fibrosis support advancement of the drug candidate into Phase 3 trials.
. | May 22, 2023
A pair of internationally known stem cell cloning researchers from the University of Houston have reported their discovery of mutant cells in the lungs of patients with Idiopathic Pulmonary Fibrosis (IPF), which will most likely be crucial targets in any future treatment for the ailment.
Aldafermin demonstrated statistically significant reductions in serum 7αC4 and fecal bile acids versus placebo in patients with idiopathic BAM with IBS-DAround 25-50% of patients with. | May 8, 2023
MyJournals.org - Science - IJMS, Vol. 24, Pages 7849: Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review (International Journal of Molecular Sciences)